Cabozantinib, a new standard of care for patients with advanced renal cell carcinoma and bone metastases? Subgroup analysis of the METEOR trial

1. Escudier, B.
2. Powles, T.
3. Motzer, R.J.
4. Olencki, T.
5. Frontera, O.A.
6. Oudard, S.
7. Rolland, F.
8. Tomczak, P.
9. Castellano, D.
10. Appleman, L.J.
11. Drabkin, H.
12. Vaena, D.
13. Milwee, S.
14. Youkstetter, J.
15. Lougheed, J.C.
16. Bracarda, S.
17. Choueiri, T.K.